Literature DB >> 27507811

Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor κB (RANK) Signaling Complex Enhances Osteoclastogenesis.

Jiyeon Yu1, Hyeongseok Yun1, Bongjin Shin1, Yongjin Kim1, Eui-Soon Park1, Seunga Choi1, Jungeun Yu1, Dulshara Sachini Amarasekara1, Sumi Kim1, Jun-Ichiro Inoue2, Matthew C Walsh3, Yongwon Choi3, Masamichi Takami4, Jaerang Rho5.   

Abstract

The signaling pathway downstream of stimulation of receptor activator of nuclear factor κB (RANK) by RANK ligand is crucial for osteoclastogenesis. RANK recruits TNF receptor-associated factor 6 (TRAF6) to TRAF6-binding sites (T6BSs) in the RANK cytoplasmic tail (RANKcyto) to trigger downstream osteoclastogenic signaling cascades. RANKcyto harbors an additional highly conserved domain (HCR) that also activates crucial signaling during RANK-mediated osteoclastogenesis. However, the functional cross-talk between T6BSs and the HCR in the RANK signaling complex remains unclear. To characterize the cross-talk between T6BSs and the HCR, we screened TRAF6-interacting proteins using a proteomics approach. We identified Vav3 as a novel TRAF6 binding partner and evaluated the functional importance of the TRAF6-Vav3 interaction in the RANK signaling complex. We demonstrated that the coiled-coil domain of TRAF6 interacts directly with the Dbl homology domain of Vav3 to form the RANK signaling complex independent of the TRAF6 ubiquitination pathway. TRAF6 is recruited to the RANKcyto mutant, which lacks T6BSs, via the Vav3 interaction; conversely, Vav3 is recruited to the RANKcyto mutant, which lacks the IVVY motif, via the TRAF6 interaction. Finally, we determined that the TRAF6-Vav3 interaction resulting from cross-talk between T6BSs and the IVVY motif in RANKcyto enhances downstream NF-κB, MAPK, and NFATc1 activation by further strengthening TRAF6 signaling, thereby inducing RANK-mediated osteoclastogenesis. Thus, Vav3 is a novel TRAF6 interaction partner that functions in the activation of cooperative signaling between T6BSs and the IVVY motif in the RANK signaling complex.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  NFAT transcription factor; mitogen-activated protein kinase (MAPK); osteoclast; osteoporosis; signal transduction

Mesh:

Substances:

Year:  2016        PMID: 27507811      PMCID: PMC5034056          DOI: 10.1074/jbc.M116.728303

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Vav-family proteins in T-cell signalling.

Authors:  Victor L J Tybulewicz
Journal:  Curr Opin Immunol       Date:  2005-06       Impact factor: 7.486

2.  IL-1 mediates TNF-induced osteoclastogenesis.

Authors:  Shi Wei; Hideki Kitaura; Ping Zhou; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  D-chiro-inositol negatively regulates the formation of multinucleated osteoclasts by down-regulating NFATc1.

Authors:  Jungeun Yu; Seunga Choi; Eui-Soon Park; Bongjin Shin; Jiyeon Yu; Seoung Hoon Lee; Masamichi Takami; Jong Soon Kang; Hyungun Meong; Jaerang Rho
Journal:  J Clin Immunol       Date:  2012-06-19       Impact factor: 8.317

4.  Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis.

Authors:  Joel Jules; Ping Zhang; Jason W Ashley; Shi Wei; Zhenqi Shi; Jianzhong Liu; Suzanne M Michalek; Xu Feng
Journal:  J Biol Chem       Date:  2012-03-13       Impact factor: 5.157

5.  Identification and characterization of anti-osteoclastogenic peptides derived from the cytoplasmic tail of receptor activator of nuclear factor kappa B.

Authors:  Yuu Taguchi; Yoko Kiga; Jin Gohda; Jun-Ichiro Inoue
Journal:  J Bone Miner Metab       Date:  2012-04-28       Impact factor: 2.626

6.  v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.

Authors:  Seoung-Hoon Lee; Jaerang Rho; Daewon Jeong; Jai-Yoon Sul; Taesoo Kim; Nacksung Kim; Ju-Seob Kang; Takeshi Miyamoto; Toshio Suda; Sun-Kyeong Lee; Robert J Pignolo; Boguslawa Koczon-Jaremko; Joseph Lorenzo; Yongwon Choi
Journal:  Nat Med       Date:  2006-11-26       Impact factor: 53.440

7.  The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis.

Authors:  Teiji Wada; Tomoki Nakashima; Antonio J Oliveira-dos-Santos; Juerg Gasser; Hiromitsu Hara; Georg Schett; Josef M Penninger
Journal:  Nat Med       Date:  2005-03-06       Impact factor: 53.440

Review 8.  Vav proteins, masters of the world of cytoskeleton organization.

Authors:  Idit Hornstein; Andres Alcover; Shulamit Katzav
Journal:  Cell Signal       Date:  2004-01       Impact factor: 4.315

9.  The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.

Authors:  B R Wong; R Josien; S Y Lee; M Vologodskaia; R M Steinman; Y Choi
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

10.  TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL.

Authors:  Matthew C Walsh; Gregory K Kim; Paul L Maurizio; Elizabeth E Molnar; Yongwon Choi
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240

View more
  8 in total

Review 1.  Regulation of Osteoclast Differentiation by Cytokine Networks.

Authors:  Dulshara Sachini Amarasekara; Hyeongseok Yun; Sumi Kim; Nari Lee; Hyunjong Kim; Jaerang Rho
Journal:  Immune Netw       Date:  2018-02-07       Impact factor: 6.303

2.  TRAF6 Plays a Proviral Role in Tick-Borne Flavivirus Infection through Interaction with the NS3 Protease.

Authors:  Brian H Youseff; Thomas G Brewer; Kristin L McNally; Adaeze O Izuogu; Kirk J Lubick; John B Presloid; Saad Alqahtani; Saurabh Chattopadhyay; Sonja M Best; Xiche Hu; R Travis Taylor
Journal:  iScience       Date:  2019-05-11

3.  Cervus and cucumis peptides ameliorates bone erosion in experimental arthritis by inhibiting osteoclastogenesis.

Authors:  Ze-Min Lin; Yu-Ting Liu; Yan-Sheng Xu; Xiao-Qian Yang; Feng-Hua Zhu; Wei Tang; Shi-Jun He; Jian-Ping Zuo
Journal:  Lupus Sci Med       Date:  2019-05-12

4.  TDAG51 is a crucial regulator of maternal care and depressive-like behavior after parturition.

Authors:  Hyeongseok Yun; Eui-Soon Park; Seunga Choi; Bongjin Shin; Jungeun Yu; Jiyeon Yu; Dulshara Sachini Amarasekara; Sumi Kim; Nari Lee; Jong-Soon Choi; Yongwon Choi; Jaerang Rho
Journal:  PLoS Genet       Date:  2019-06-28       Impact factor: 5.917

5.  MicroRNA Alterations for Diagnosis, Prognosis, and Treatment of Osteoporosis: A Comprehensive Review and Computational Functional Survey.

Authors:  Hai Hu; Xiaodi He; Yazhong Zhang; Rongrong Wu; Jiajia Chen; Yuxin Lin; Bairong Shen
Journal:  Front Genet       Date:  2020-03-03       Impact factor: 4.599

6.  T-Cell Death Associated Gene 51 Is a Novel Negative Regulator of PPARγ That Inhibits PPARγ-RXRα Heterodimer Formation in Adipogenesis

Authors:  Sumi Kim; Nari Lee; Eui-Soon Park; Hyeongseok Yun; Tae-Uk Ha; Hyoeun Jeon; Jiyeon Yu; Seunga Choi; Bongjin Shin; Jungeun Yu; Sang Dal Rhee; Yongwon Choi; Jaerang Rho
Journal:  Mol Cells       Date:  2021-01-31       Impact factor: 5.034

7.  Pax5 Negatively Regulates Osteoclastogenesis through Downregulation of Blimp1.

Authors:  Jiyeon Yu; Sumi Kim; Nari Lee; Hyoeun Jeon; Jun Lee; Masamichi Takami; Jaerang Rho
Journal:  Int J Mol Sci       Date:  2021-02-20       Impact factor: 5.923

8.  Bisphosphonate-enoxacin inhibit osteoclast formation and function by abrogating RANKL-induced JNK signalling pathways during osteoporosis treatment.

Authors:  Qiang Xu; Ping Zhan; Xiaofeng Li; Fengbo Mo; Huaen Xu; Yuan Liu; Qi Lai; Bin Zhang; Min Dai; Xuqiang Liu
Journal:  J Cell Mol Med       Date:  2021-10-15       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.